* Cubist Pharmaceuticals Inc., of Cambridge, Mass., appointedFrancis Tally to vice president, research and development.

* Sepracor Inc., of Marlborough, Mass., hired Douglas Reedich aschief patent counsel and Paulina Hall as senior director of regulatoryaffairs.

* Prizm Pharmaceuticals Inc., of San Diego, said one of its scientificfounders, Andrew Baird, joined the company full time as vicepresident, research and development.

* RiboGene Inc., of Hayward, Calif., appointed Timothy Morris asvice president, finance and administration, and chief financial officer.

* Amgen Inc., of Thousand Oaks, Calif., hired George Vandeman assenior vice president, general counsel and corporate secretary.

* Cytogen Corp., of Princeton, N.J., elected Donald O'Neill to itsboard of directors.

* Ligand Pharmaceuticals Inc., of San Diego, elected HenryBlissenbach and John Groom to its board of directors. They replaceHoward Birndorf and Robert Curry.

(c) 1997 American Health Consultants. All rights reserved.